1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Lpu School Of Pharmaceutical Sciences Developed An Anti-Cancer Medicine

This new technology is useful in overcoming the side effects of the drugs used in treatment of colon cancer and has been developed indigenously by the dean, faculty of Applied Medical Sciences, Dr. Monica Gulati and her team at LPU.

 
PRLog - Jun. 15, 2012 - HYDERABAD, India -- Hyderabad, June 15, 2012: The School of Pharmaceutical Sciences of Lovely Professional University (LPU) has got their patent (PCT) published in 140 countries for the development of Targeted Release Microsphere of 5-FU (5-fluorouracil) vide Publication No. WO/ 2012/035561. This new technology is useful in overcoming the side effects of the drugs used in treatment of colon cancer and has been developed indigenously by the dean, faculty of Applied Medical Sciences, Dr. Monica Gulati and her team at LPU.

Realizing the potential of the invention, an MOU has been signed between LPU and a premier pharmaceutical company Rhydburg at Dehradun in India. Rhydburg is one of the top manufacturers and exporters of pharmaceuticals- tablets, injections, beta lactam, syrups, capsules etc.
Extending felicitations to Dr. Gulati and her team from university’s School of Pharmaceutical Sciences for their remarkable achievement, Mr. Ashok Mittal, Chancellor, LPU said, “The research facilities at the University are being extended to aim at the world class innovations & research in the university. The present patent which has already been published for 140 countries has further motivated us to perform better.”

He added, “During severe medical treatments, certain side effects of many medicines have claimed human lives, leading to an incalculable precious drain on human talent and resources. This development is indeed a great endeavour towards welfare of humanity.”
Speaking in this context, the Managing Director of Rhydburg, Mr. Ashok Monga, said, “ With team of LPU coming out with such a needed medicine, we can easily make out that India is fast realizing its intellectual potential and the next era will see a lot more technological advancements from Indian Scientists like those at LPU.”
Highlighting the importance of the anti-cancer medicine Dr. Gulati explained more about the side effects of colon cancer treatment. She informed, “The side-effects depend on the type of treatment and differ from person to person. In general, anticancer drugs affect cells that divide rapidly especially blood cells, cells in hair roots & cells that line the digestive tract. When drugs affect these cells, patients are more likely to get infections, bruise, hair loss, poor appetite, nausea, vomiting, diarrhea, mouth & lip sores or feel very weak and tired.  Almost similar effects can occur during Radiation and Biological therapy. However, many of these side effects of colon cancer chemotherapy can be controlled with drugs.  For this reason, our Department strived to invent the remedy and further collaborated with a top pharmaceutical company.”

Illustrative, a patent for the development of Targeted Release Microsphere of 5-FU had been filed vide International patent application No.PCT/IN2011/000642.

--- End ---

Click to Share

Contact Email:
***@bluelotuspr.com Email Verified
Source:Blue Pearls
Phone:914065792800
Zip:500003
City/Town:Hyderabad - Andhra Pradesh - India
Industry:Health
Tags:lpu, anti cancer, medicine
Shortcut:prlog.org/11900667
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share